These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14077373)

  • 21. ATRIOVENTRICULAR BLOCK: A CLINICAL STUDY.
    ZION MM; BRADLOW BA
    S Afr Med J; 1964 Feb; 38():144-8. PubMed ID: 14127767
    [No Abstract]   [Full Text] [Related]  

  • 22. COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.
    EISEN MJ
    JAMA; 1964 Jul; 189():64-5. PubMed ID: 14149032
    [No Abstract]   [Full Text] [Related]  

  • 23. [SOME PROBLEMS CONCERNING THE TREATMENT OF CARDIAC INFARCT, WITH SPECIAL REFERENCE TO ANTICOAGULANT THERAPY].
    GOEMOERI P
    Orv Hetil; 1963 Dec; 104():2310-1. PubMed ID: 14097808
    [No Abstract]   [Full Text] [Related]  

  • 24. [Practical use of anti-prothrombin treatments].
    Chiche P; Berkman M; Savier CH
    Sem Ther; 1967 Oct; 43(8):448-9. PubMed ID: 5623992
    [No Abstract]   [Full Text] [Related]  

  • 25. OUTPATIENT ANTICOAGULATION: A PROBLEM IN LONG-TERM MANAGEMENT.
    BEINSTEIN J
    Va Med Mon (1918); 1964 Apr; 91():149-54. PubMed ID: 14140408
    [No Abstract]   [Full Text] [Related]  

  • 26. [COMPRESSIVE HEMOPERICARDIUM FOLLOWING AN ANTICOAGULANT TREATMENT FOR MYOCARDIAL INFARCT. SURGICAL TREATMENT].
    HOUEL J; PASQUET P; PONS R; MALMEJAC C
    Mars Med; 1964; 101():555-8. PubMed ID: 14177120
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of coumarine derivatives on the activity of some exoenzymes of the pancreas and mucous membrane of the small intestine].
    Bogdanov NG; Lider VA
    Farmakol Toksikol; 1967; 30(6):727-9. PubMed ID: 5598448
    [No Abstract]   [Full Text] [Related]  

  • 28. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

  • 29. ATTEMPTED REDUCTION OF ADHESIVE PLATELETS AFTER CARDIAC INFARCTION.
    EASTHAM RD
    Lancet; 1964 Sep; 2(7359):541-3. PubMed ID: 14172343
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE USE OF 2831 R.P. (COREPTIL) IN CARDIOVASCULAR DISEASE. REVIEW OF THE LITERATURE AND PERSONAL CONTRIBUTION].
    MARTELLI A; ROSSI S
    Arch Sci Med (Torino); 1963 Nov; 116():314-28. PubMed ID: 14098820
    [No Abstract]   [Full Text] [Related]  

  • 31. [MODIFICATION OF ANTICOAGULANT THERAPY BY A DIURETIC].
    VINAZZER H
    Wien Z Inn Med; 1963 Jul; 44():323-7. PubMed ID: 14048088
    [No Abstract]   [Full Text] [Related]  

  • 32. [REHABILITATION IN HEART DISEASE].
    KOBAYASHI T; TAKEUCHI M
    Chiryo; 1963 Oct; 45():1881-90. PubMed ID: 14094264
    [No Abstract]   [Full Text] [Related]  

  • 33. [CLINICAL EXPERIMENTATION WITH A NEW SYNTHETIC ANTICOAGULANT, A COUMARIN DERIVATIVE: 1-METHOXY-2, 2-BIS (4-HYDROXY-3-COUMARINYL)-ETHANE].
    HUTINEL P
    Lyon Med; 1964 Jun; 211():1569-604. PubMed ID: 14161671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man].
    Blatrix C; Charonnat S; Tillement JP; Israel J; Brevet JP; Debraux J; Merlin M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):984-95. PubMed ID: 4185223
    [No Abstract]   [Full Text] [Related]  

  • 35. Dicoumarin compounds in the treatment of the pigment degeneration of the retina.
    MERZ MO; PIOTROWSKI A
    Ophthalmologica; 1963; 145():249-56. PubMed ID: 13935089
    [No Abstract]   [Full Text] [Related]  

  • 36. USE OF ANTICOAGULANT FOR CARDIOVASCULAR DISEASES WITH SPECIAL EMPHASIS OF THE INCIDENCE OF THROMBOEMBOLISM IN JAPAN.
    IKEDA M
    Yokufuen Chosa Kenkyu Kiyo; 1963 Dec; 38():1-16. PubMed ID: 14134975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myocardial infarct as a stochastic manifestation].
    Drdková S; Zaloudek M
    Cesk Zdrav; 1969; 17(10):437-9. PubMed ID: 5343835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prothrombin time and heparin time during pelentan therapy].
    CERMAK L; HOBZA A; POKORNY J
    Pol Tyg Lek (Wars); 1956 Sep; 11(37):1577-8. PubMed ID: 13388837
    [No Abstract]   [Full Text] [Related]  

  • 39. [ON EXPERIENCES WITH ANTICOAGULANT THERAPY IN MYOCARDIAL INFARCT].
    ANDERS G; SCHROETER RM; HEINE H
    Dtsch Gesundheitsw; 1964 Jan; 19():81-5. PubMed ID: 14181393
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of heparin and pelentan on the biopolymer metabolism of connective tissue in myocardial infarct].
    Sharaev PN; Leshchinskiĭ LA; Pimenov LT; Vtorov AE
    Farmakol Toksikol; 1984; 47(1):44-6. PubMed ID: 6705903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.